It is worth noting that this trend is consistent with the results of functional experiments (GABRP knockdown inhibits tumor growth) and pathway enrichment, suggesting that its potential clinical significance needs to be verified in a larger cohort with clear molecular typing. This evidence concerns the gene GABRP and neoplasm.